[ad_1]
Prime Minister Boris Johnson on Monday dampened prospects of an efficient coronavirus vaccine by the top of this year, as preliminary outcomes of a widely-followed human trial on the University of Oxford had been resulting from be launched later within the day.
On a go to to Kent, Johnson, who recovered after being severely affected by the virus earlier this year, stated: “I wish I could say that I was 100% confident that we will get a vaccine for Covid-19 (this year). As you know, there are about 100 different scientific ventures out in the field now”.
Follow latest updates on coronavirus right here
“The UK has got some world-leading scientists engaged in this. There’s the Oxford programme where we have secured 100m doses already. What we are saying today is we’re investing also in a couple of potential vaccines, one French, one German – 90 million doses that we’re going to be investing in”.
However, he went on to say in a pooled media interplay: “Obviously I’m hopeful. I’ve got my fingers crossed. But to say that I’m 100% confident that we’ll get a vaccine this year, or indeed next year, that is, alas, an exaggeration. We are not there yet”.
Also learn: UK firm declares positive results from Covid-19 protein treatment
“If you talk to the scientists, they think that the sheer weight of international effort is going to produce something. They are pretty confident that we’ll get some sorts of treatments, some sorts of vaccines, that really make a difference”.
Click here for complete coronavirus coverage
“But right now can I tell you that I’m 100% confident? No. That’s why we’ve got to continue with our current approach, maintaining social distancing measures … washing hands … wearing face masks in confined spaces like on public transport or in shops”.
“And then we will continue to drive the virus down by our own collective action. It may be that the vaccine is going to come riding over the hill like the cavalry. But we just can’t count on it right now”, he added.
Also learn: Awaiting trials success, UK seals early access to 3 Covid-19 vaccine candidates
Johnson’s feedback got here quickly after Business secretary Alok Sharma introduced new offers to safe early entry to 3 promising Covid-19 vaccine candidates. The Johnson authorities has allotted hundreds of thousands of kilos for mass-production of vaccines if trials are profitable.
The three vaccine courses that the Boris Johnson authorities has secured by partnerships are: adenoviral vaccines (University of Oxford/AstraZeneca); mRNA vaccines (BioNTech/Pfizer, Imperial College London) and the inactivated entire virus vaccines (Valneva).
[ad_2]
Source link